Non-genotoxic hepatocarcinogenesis: Suppression of apoptosis by peroxisome proliferators

Annals of the New York Academy of Sciences

Volumn 804, Issue , 1996, Pages 588-611

  Roberts, Ruth A ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; INOSITOL PHOSPHATE; PEROXISOME PROLIFERATOR; PROTEIN KINASE C; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL GROWTH; CONFERENCE PAPER; DNA SYNTHESIS; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; LIVER CARCINOGENESIS; LIVER CELL; MITOSIS; PEROXISOME;

EID: 0030462771     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb18647.x     Document Type: Conference Paper

References (97)

1. REDDY, J. K., D. L. AZARNOFF & C. E. HIGNITE. 1980. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283: 397-398.
2. MOODY, D. E., J. K. REDDY, B. G. LAKE, J. A. POPP & D. H. REESE. 1991. Peroxisome proliferation and non-genotoxic carcinogenesis: Commentary on a symposium. Fund. Appl. Toxicol. 6: 233-248.
3. ASHBY, J., A. BRADY, C.R. ELCOMBE, B. M. ELLIOT, J. ISHMAEL, J. ODUM, J. D. TUGWOOD, S. KETTLE & I. F. H. PURCHASE. 1994. Mechanistically-based human hazard assessment of peroxisome-proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13: S1-S117.
4. COHEN, S. M. & L. B. ELLWEIN. 1989. Cell proliferation in carcinogenesis. Science 249: 1007-1011.
5. OBERHAMMER, F. A. & R. A. ROBERTS. 1994. Apoptosis: A widespread process involved in liver adaptation and carcinogenesis. In The Liver: Biology and Pathobiology. I. M. Arias, J. L. Boyer, N. Fausto, W. B. Jakoby, D. Schachter & D. A. Shafritz, Eds. 1547-1556. Raven Press. New York.
6. ALISON, M. R. & C. E. SARRAF. 1995. Apoptosis: Regulation and relevance to toxicology. Hum. Exp. Toxicol. 14: 234-247.
7. BAYLY, A. C., R. A. ROBERTS & C. DIVE. 1995. Mechanisms of Apoptosis. In Advances in Molecular and Cell Biology: Mechanisms of Cell Toxicity. In press.
8. GERBRACHT, U., W. BURSCH, P. KRAUS, B. PUTZ, M. REINACHER, I. TIMMERMAN-TROSIENER & R. SCHULTE-HERMANN. 1990. Effects of the hypolipidaemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver. Carcinogenesis 11: 617-624.
9. BAYLY, A. C., N. J. FRENCH, C. DIVE & R. A. ROBERTS. 1993. Non-genotoxic hepatocarcinogenesis in vitro: The FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis. J. Cell Sci. 104: 307-315.
10. BAYLY, A. C., R. A. ROBERTS & C. DIVE. 1994. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator, nafenopin. J. Cell Biol. 125: 197-203.
11. JAMES, N. H. & R. A. ROBERTS. 1994. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergise with epidermal growth factor to promote the clonal expansion of initiated rat hepatocytes. Carcinogenesis 15: 2687-2694.
12. JAMES, N. H. & N. H. ROBERTS. 1995. Species differences in clonal expansion of hepatocytes in response to the co-action of epidermal growth factor and nafenopin, a rodent hepatocarcinogenic peroxisome proliferator. Fund. Appl. Toxicol. 25: in press.
13. ISSEMANN, I. & S. GREEN. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-650.
14. TUGWOOD, J. D., I. ISSEMANN, R. G. ANDERSON, K. R. BUNDELL, W. L. MCPHEAT & S. GREEN. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl coA oxidase gene. EMBO J. 11: 433-439.
15. ALDRIDGE, T. C., J. D. TUGWOOD & S. GREEN. 1995. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J. 306: 473-479.
16. ASHBY, J. & R. TENNANT. 1991. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257: 229-306.
17. REDDY, J. K. & N. D. LALWANI. 1983. Carcinogenesis by hepatic peroxisome proliferators. Evaluation of the risk of hypolidaemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12: 1-58.
18. MARSMANN, D. S., R. C. CATTLEY, J. G. CONWAY & J. A. POPP. 1988. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-pyramidinylthio]acetic acid (Wyeth-14,643) in rats. Cancer Res. 48: 6739-6744.
19. ELCOMBE, C. R. 1985. Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: A biochemical human hazard assessment. Arch. Toxicol.: 6-7.
20. BENTLEY, P., I. CALDER, C. ELCOMBE, P. GRASSO, H. G. WIEGAND & D. A. STRINGER. 1992. Hepatic Peroxisome Proliferation. ECETOC Monograph No. 17.
21. REDDY, J. K., M. S. RAO, D. L. AZARNOFF & S. SELL. 1979. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator Wy-14,643 in rat and mouse liver. Cancer Res. 39: 152-160.
22. NTP (NATIONAL TOXICOLOGY PROGRAM) (1982): NTP technical report on the carcinogenesis bioassay of DEHP in F344 rats and B6C3F1 mice (feed study).
23. BENTLEY, P., I. CALDER, E. ELCOMBE, P. GRASSO, D. STRINGER & H. J. WIEGAND. 1993. Hepatic peroxisome proliferation in rodents and its significance to humans. Fund. Chem. Toxicol. 31: 857-907.
24. ELCOMBE, C. R. & A. MITCHELL. 1986. Peroxisome proliferation due to di(2-ethylhexyl)-phthalate: Species differences and possible mechanisms. Environ. Health Perspect. 70: 211-219.
25. LAKE, B. G., J. G. EVANS, T. J. B. GRAY, S. A. KÖRÖSI & C. J. NORTH. 1989. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig and marmoset. Toxicol. Appl. Pharmacol. 99: 148-160.
26. EACHO, P. I., P. S., FOXWORTHY, R. D. DILLARD, C. A. WHITESITT, D. K. HERRON & W. S. MARSHALL. 1986. Hepatic peroxisomal changes induced by tetrazole-substituted alkoxyacetophenone in rats and comparison with other species. Toxicol. Appl. Pharmacol. 83: 430-437.
27. WATANABE, T., S. HORIE, J. YAMADA, M. ISAJI, T. NISHIGAKI, J. NAITO & T. SUGA. 1989. Species differences in the effects of bezafibrate, a hypolipidaemic agent, on hepatic peroxisome associated enzymes. Biochem. Pharmacol. 38: 430-437.
28. FOXWORTHY, P. S., S. L. WHITE, D. M. HOOVER & P. I. EACHO. 1990. Effects of ciprofibrate, bezafibrate and LY171883 on peroxisomal beta-oxidation in cultured rat, dog and rhesus monkey hepatocytes. Toxicol. Appl. Pharmacol. 104: 386-394.
29. MAKOWSKA, J. M., F. W. BONNER & G. G. GIBSON. 1991. Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset. Arch. Toxicol. 65: 106-113.
30. BIERI, F., W. STAUBLI, F. WAECHTER, S. MUAKKASAH-KELLY & P. BENTLEY. 1988. Stimulation of DNA synthesis but not of peroxisomal beta-oxidation by nafenopin in primary cultures of marmoset hepatocytes. Cell Biol. Int. Rep. 12: 1077-1087.
31. HANEFELD, M., C. HEMMER & E. KADNER. 1983. Relationship between morphological changes and lipid lowering action of p-chlorophenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis. 46: 239-246.
32. AMES, B. N. & L. S. GOLD. 1990. Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science 249: 970-971.
33. REDDY, J. K. & M. S. RAO. 1989. Oxidative DNA damage caused by persistent peroxisome proliferation: Its role in hepatocarcinogenesis. Mutat. Res. 214: 63-68.
34. CLAYSON, D. P., R. MEHTA & F. IVERSON. 1994. Oxidative DNA damage - the effects of certain genotixic and operationally non-genotoxic carcinogens. Mutat. Res. 317: 25-42.
35. MARSMAN, D. S., C. C. RUSSELL, R. C. CATTLEY, J. G. CONWAY & J. A. POPP. 1988. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyramidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 48: 6739-6744.
36. CATTLEY, R. C., D. S. MARSMANN & J. A. POPP. 1991. Age-related susceptibility to the carcinogenic effects of the peroxisome proliferator, Wy-14,643 in rat liver. Carcinogenesis 12: 469-473.
37. KRAUPP-GRASSL, D., W. HUBER, H. TAPER & R. SCHULTE-HERMANN. 1991. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res. 51: 666-671.
38. RICHARDSON, F. C., M. C. DYROFF, J. A. BOUCHERON & J. A. SWENBERG. 1985. Differential repair of 04-alkylthymidine following exposure to methylating and ethylating hepatocarcinogens. Carcinogenesis 6: 625-629.
39. KATO, M., J. A. POPP, R. B. CONOLLY & R. C. CATTLEY. 1993. Relationship between hepatocyte necrosis, proliferation and initation induced by diethylnitrosamine in the male F344 rat. Fund. App. Tox. 20: 155-162.
40. NEUMANN, F. 1994. The antiandrogen cyproterone acetate: Discovery, chemistry basic pharmacology, clinical use and tool in basic research. Exp. Clin. Endocrinol. 102: 1-32.
41. BURSCH, B., B. LAUER, I. TIMMERMAN-TROSIENER, G. BARTHEL, J. SCHUPPLER & R. SCHULTE-HERMANN. 1984. Controlled death (apoptosis) of normal and preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 5: 453-458.
42. BURSCH, W., B. DUSTERBERG & R. SCHULTE-HERMANN. 1986. Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate. Arch. Toxicol. 59: 221-227.
43. BURSCH, W., F. OBERHAMMER & R. SCHULTE-HERMANN. 1992. Cell death by apoptosis and its protective role against disease. Trends Physiol. Sci. 13: 245-251.
44. ROBERTS, R. A., A. R. SOAMES, J. H. GILL, N. H. JAMES & E. B. WHEELDON. 1995. Non-genotoxic hepatocarcinogens induce DNA synthesis and their withdrawal induces apoptosis but in discrete hepatocyte populations. Carcinogenesis. In press.
45. CONCORAN, G. B., L. FIX, D. P. JONES, M. T. MOSLEN, P. NICOTERA, F. A. OBERHAMMER & R. BUTTYAN. 1994. Contemporary issues in toxicology. Apoptosis: Molecular control point in toxicity. Toxicol. Appl. Pharmacol. 128: 169-181.
46. WYLLIE, A. H. 1993. Apoptosis (The Frank Rose Memorial Lecture). Br. J. Cancer 67: 205-208.
47. TRUMP, B. F., I. I. K. BEREZESKY & A. R. OSORNIO-VARGAS. 1981. Cell death and the disease process: Role of calcium. In Cell Death in Biology and Pathology. I. D. Bowen & R. A. Lockshin, Eds.: 209-241. Chapman and Hall.
48. WYLLIE, A. H. 1980. Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 4: 555-556.
49. WYLLIE, A. H. 1995. The genetic regulation of apoptosis. Curr. Opin. Gen. Devel. 5: 97-104.
50. DUVALL, E. & A. H. WYLLIE. 1986. Death and the cell. Immunol. Today 7: 115-119.
51. GERSCHENSON, L. E. & R. J. ROTELLO. 1992. Apoptosis: A different type of cell death. FASEB J. 6: 2450-2455.
52. TESSITORE, L., G. BONELLI & F M. BACCINO. 1987. Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem. J. 241: 153-159.
53. SCHWARTZMAN, R. A. & J. A. CIDLOWSKI. 1993. Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocrine Rev. 14: 133-151.
54. GILL, J. H., C. M. MOLLOY, K. SHOESMITH, A. C. BAYLY & R. A. ROBERTS. 1995. The rodent non-genotoxic hepatocarcinogen nafenopin and EGF alter the mitosis/apoptosis balance promoting hepatoma clonal growth. Cell Death and Differentiation. In Press.
55. ARENDS, M. J., R. G. MORRIS & A. H. WYLLIE. 1990. Apoptosis: The role of the endonuclease. Am. J. Pathol. 136: 593-608.
56. OBERHAMMER, F., W. BURSCH, W. PARZEFALL, P. BREIT, E. ERBER, M. STADLER & R. SCHULTE-HERMANN. 1991. Effect of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res. 51: 2478-2485.
57. OBERHAMMER, F., G. FRITSCH, M. SCHMIED, M. PAVELKA, D. PRINTZ, A.F. PURCHIO, H. LASSMANN & R. SCHULTE-HERMANN. 1993. Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J. Cell Sci. 104: 317-326.
58. BOE, R., B. T. GJERTSEN, O. K. VINTERMYR, G. HOUGE & S. O. DOSKELAND. 1991. The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp. Cell Res. 195: 237-246.
59. ZAKERI, Z. F., D. QUAGLINO, T. LATHAM & R. A. LOCKSHIN. 1993. Delayed internucleosomal DNA fragmentation in programmed cell death. FASEB J. 7: 470-478.
60. WALKER, P. R., C. SMITH, T. YOUDALE, J. LEBLANC, J. F. WHITFIELD & M. SIKORSKA. 1991. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res. 51: 1078-1085.
61. OBERHAMMER, F., J. W. WILSON, C. DIVE, I. D. MORRIS, J. A. H. HICKMAN, A. E. WAKELING & P. R. WALKER. 1993. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50Kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12: 3679-3684.
62. BROWN, D. G., X.-M. SUN & G. M. COHEN. 1993. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 268: 3037-3039.
63. FILIPSKI, J., J. LEBLANC, J. YOUDALE, M. SIKORSKA & P. R. WALKER. 1990. Periodicity of DNA folding in higher order chromatin structures. EMBO J. 9: 1319-1327.
64. WALKER, P. R., L. KOKILEVA, J. LEBLANC & M. SIKORSKA. 1993. Detection of the initial stages of DNA fragmentation in apoptosis. Biotechniques 15: 1032-1040.
65. WEAVER, A. M., B. LACH, P. R. WALKER & M. SIKORSKA. 1993. Role of proteolysis in apoptosis: Involvement of serine proteases in internucleosomal DNA fragmentation in immature thymocytes. Biochem. Cell Biol. 71: 488-500.
66. SCHULTE-HERMANN, R., W. BURSCH, B. KRAUPP-GRASL, F. OBERHAMMER, A. WAGNER & R. JIRTLE. 1993. Cell proliferation and apoptosis in normal liver and preneoplastic liver foci. Environ. Health Perspect. 101: 97-90.
67. GRISHAM, J. W., M. TASAO, D. C. LEE & H. SHELTON. 1990. Sequential changes in epidermal growth factor receptors/ligand function in cultured rat liver epithelial cells transformed chemically in vitro. Pathobiol. Neoplasia 58: 3-14.
68. JOHANSSON, S., N. ANDERSSON & G. ANDERSSON. 1990. Pretranslational and posttranslational regulation of the EGF receptor during the prereplicative phase of liver regeneration. Hepatol. 12: 533-541.
69. ARENDS, M. J., A. J. MCGREGOR & A. WYLLIE. 1994. Apoptosis is inversely related to necrosis and determines net growth rate in tumours bearing constitutively expressed myc, ras and HPV oncogenes. Am. J. Pathol. 144: 1047-1057.
70. FARBER, E. 1990. Clonal adaptation during carcinogenesis. Biochem. Pharmacol. 39: 1837-1846.
71. ORELLANA, A., L. LOLUIGUE, P. C. HIDALGO, V. FAUNDEZ, A. GONZALEZ & M. BRONFMAN. 1993. Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of the epidermal growth factor receptor. Eur. J. Biochem. 215: 903-906.
72. SCHULTE-HERMANN, R., I. TIMMERMANN-TROSIENER & J. SCHUPPLER. 1982. Response of liver foci in rats to hepatic tumour promoters. Toxicol. Pathol. 10: 63-70.
73. KRAUPP-GRASL, B., W. HUBER, I. TIMMERMANN-TROSIENER & R. SCHULTE-HERMANN. 1993. Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic foci of rats treated with a single dose of the peroxisome proliferator, nafenopin. Carcinogenesis 14: 2435-2437.
74. BARRASS, N. C., R. J. PRICE, B. G. LAKE & T. C. ORTON. 1993. Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver. Carcinogenesis 14: 1451-1456.
75. EACHO, P. I., P. L. LANIER & C. A. BRODHECKER. 1991. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: Comparison of WY-14,643 to clofibric acid, nafenopin and LY-171883. Carcinogenesis 12: 1557-1561.
76. SCHULTE-HERMANN, R., V. HOFFANN, W. PARZEFALL, M. KALLENBACH, A. GERHARDT & J. SCHUPPLER. 1980. Adaptive responses of the liver to the gestagen and anti-androgen cyproterone acetate and other inducers. II. Induction of growth. Chem.-Biol. Interact. 31: 287-300.
77. KRAJEWSKI, S., M. KRAJEWSKI, A. SHABAIK, H. G. WANG, S. IRIE, L. FONG & J. C. REED. 1994. Immunohistochemical analysis of in vivo patterns of Bcl-x expression. Cancer Res. 54: 5501-5507.
78. KRAJEWSKI, S., M. KRAJEWSKI, A. SHABAIK, H. G. WANG, T. MIYASHITA & J. C. REED. 1994. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Path 145: 1323-1336.
79. OCHSNER, M., J. CREBA, J. WALKER, P. BENTLEY & S. MUAKASSAH-KELLY. 1990. Nafenopin, a hypolipidemic and non-genotoxic hepatocarcinogen increases intracellular calcium and transiently decreases intracellular pH in hepatocytes without generation of inositol phos7 phates. Biochem. Pharmacol. 40: 2247-2257.
80. MCCONKEY, D. J., S. ORRENIUS & M. JONDAL. 1990. Cellular signalling in programmed cell death (apoptosis). Immunol. Today 11: 120-121.
81. DUKE, R. C., R. Z. WITTER, P. S. NASH, J. D. E. YOUNG & D. M. OJICUS. 1994. Cytolysis mediated by ionophores and pore forming agents: Role of intracellular calcium in apoptosis. FASEB J. 8: 237-246.
82. 2+ fluxes. Proc. Natl. Acad. Sci. USA 91: 6569-6573.
83. NELSESTUAN, G. L. & M. D. BAZZI. 1991. Activation and regulation of protein kinase C enzymes. Bioenerget. Biomem. 23: 43-61.
84. BRONFMAN, M., A. ORELLANA, M. N. MORALES, F. BIERI, F. WAECHTER, W. STAUBLI & P. BENTLEY. 1989. Potentiation of diacylglycerol-activated protein kinase C by acyl-coenzyme A thioesters of hypolipidemic drugs. Biochem. Biophys. Res. Commun. 159: 1026-1031.
85. ORELLANA, A., P. C. HIDALGO, M. N. MORALES, D. MEZZANO & M. BRONFMAN. 1990. Palmitoyl-CoA and the acyl-CoA thioester of the carcinogenic peroxisome proliferator ciprofibrate potentiate diacylglycerol-activated protein kinase C by decreasing the phosphatidyl serine requirement of the enzyme. Eur. J. Biochem. 190: 57-61.
86. WATANABE, T., S. OKAWA, H. ITOGA, T. IMANAKA & T. SUGA. 1992. Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by the hypolipidemic peroxisome proliferators. Biochem. Biophys. Acta. 1135: 84-90.
87. BIERI, F., F. WAECHTER, P. SAGELSDORFF, H. THOMAS & W. STAUBLI. 1991. Mechanistic studies on the mitogenic response induced in hepatocytes by nafenopin, a non-mutagenic hepatocarcinogen. Human and Exp. Toxicol 10: 86-87.
88. DIVE, C., C. A. EVANS & A. D. WHETTON. 1992. Induction of apoptosis - new targets for cancer chemotherapy. Semin. Cancer Biol. 3: 417-427.
89. SANCHEZ, V., M. LUCAS, A. SANZ & R. GOBERNA. 1992. Decreased protein kinase C activity is associated with programmed cell death (apoptosis) in freshly isolated rat hepatocytes. Biosci. Rep. 12: 199-206.
90. KNOX, K. A., G. D. JOHNSON & J. GORDON. 1993. A study of protein kinase C isozyme distribution in relation to bcl-2 expression during apoptosis of epithelial cells in vivo. Exp. Cell Res. 207: 68-73.
91. KORSMEYER, S. J., J. R. SHUTTER, D. J. VEIS, D. E. MERRY & Z. N. OLTVAI. 1993. Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer. Biol. 4: 327-332.
92. KORSMEYER, S. J., J. R. SHUTTER, D. J. VEIS, D. A. MERRY & Z. N. OLTVAI. 1993. A study of protein kinase C isozyme distribution in relation to Bcl-2 expression during apoptosis of epithelial cells in vivo. Exp. Cell Res. 207: 68-73.
93. DREYER, C., H. KELLER, A. MAHFOUDI, V. LAUDET, G. KREY & W. WAHLI. 1993. Positive regulation of the peroxisomal-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol. Cell 77: 67-76.
94. ZHU, Y., K. ALVARES, Q. HUANG, M. S. RAO & J. K. REDDY. 1993. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J. Biol. Chem. 268: 26817-26820.
95. SHER, T., H. F. YI, W. MCBRIDE & F. J. GONZALEZ. 1993. CDNA cloning, chromosomal mapping and functional characterisation of the human peroxisome proliferator-activated receptor. Biochem. 32: 5598-5604.
96. GEARING, K. L., M. GOTTLICHER, M. TEBOUL, E. WIDMARK & J. A. GUSTAFSSON. 1993. Interaction of the peroxisome proliferator-activated receptor and retinoid-X receptor. Proc. Natl. Acad. Sci. USA 90: 1440-1444.
97. BARDOT, O., T. C. ALDRIDGE, N. LATRUFFE & S. GREEN. 1993. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Commun. 192: 37-45.